Aims-To improve the diagnostic value of fine needle aspiration biopsy of pancreatic lesions using a simple mutation detection method based on the polymerase chain reaction (PCR). Methods-Fine needle aspirates from 21 suspected pancreatic lesions were analysed for K-ras codon 12 point mutations using solid phase minisequencing. Results-A point mutation in codon 12 of the K-ras gene was detected in 14 of 17 cases of pancreatic carcinoma. No false positive results were recorded. The concordance of the result with routine cytology was 78%. All patients diagnosed as having malignant disease on cytology also had a K-ras point mutation. Additional information on the presence of malignancy was obtained using molecular genetic analysis in two cases. Conclusions-PCR based minisequencing is a promising method for the analysis of cytological material. K-ras point mutation analysis was modified to enable it to be carried out in a clinical laboratory. Advantages of the method include its simplicity and speed. Adequate sampling guidance is important but analysis can be performed even with small amounts of cellular material.
New technologies for enhancing the diagnostic yield of fine needle aspiration cytology have been reported recently.' Visualisation of tumours using radiological methods and analysis of immunological and genetic markers have improved greatly. The most promising methods for analysing small numbers of cells are those based on the polymerase chain reaction (PCR). Solid phase minisequencing, a single nucleotide primer extension method, has been used in the analysis of both acquired and hereditary point mutations.23 This method is precise, easy to use, and readily automated.
Some malignant disorders have distinctive molecular genetic characteristics. Point mutations of codon 12 of the K-ras gene occur in up to 90% of pancreatic adenocarcinomas, a feature which may be used in the diagnosis of these cancers. 4 Alterations in the K-ras gene provide a direct approach to diagnosis and characterisation of a malignancy because their location and nature are well known and well conserved. At present, most clinical laboratory methods used to analyse cancers at the molecular level have been modified from research laboratory protocols.6 The purpose of this study was to develop and evaluate simpler methods for performing clinical molecular genetic cytology and to compare its validity with cytological findings. Solid phase minisequencing was chosen because it provides a clear, numerical result and can be easily automated.
Methods
Biopsy specimens taken from 21 consecutive patients (11 women) with suspected pancreatic cancer were analysed. The mean age of the patients was 64 years (range 32 to 96 years). The patients had been admitted to the Clinic of Radiology at Helsinki University Central Hospital for needle biopsy during 1992 and 1993 because of suspected noninfectious pancreatic lesions. Thereafter, the patients were followed for at least one year. Biopsies were performed using ultrasound guided aspiration with 0 7-0 9 x 40-150 mm disposable needles under local anaesthesia. Each needle was attached to a 10 ml syringe in a hand-held biopsy extractor (Cameco, Enebyberg, Sweden). After the samples for routine diagnostic cytology were dispensed, the residual cells were injected into 1 ml physiological saline in a 1-5 ml Eppendorf tube. Routine cytological analysis was performed on alcohol fixed cells stained using the Papanicolau method.
Each study sample was processed for storage within 45 minutes. The cells were centrifuged briefly at 10 000 rpm and the supernatant fluid discarded. The cells were stored in -70°C. The cell samples were prepared for PCR as described previously.3 7 The primers, one of which was biotinylated at the 5' end, used for nested PCR amplification of the region of interest are presented in table 1 For minisequencing analysis of the K-ras codon 12, PCR products amplified using Diagnosis ofpancreatic lesions usingfine needle aspiration cytology as having carcinomas by other means (histology and clinical examination). One patient had an intestinal lymphoma diagnosed on cytology and histology. His sample was negative on K-ras point mutation analysis.
Two patients (cases 1 and 3) had borderline R values (+ 2 SD above normal). They did not show significant aberrant incorporation on single nucleotide incorporation analysis and thus were not regarded as having point mutations. Both of these patients had pancreatic adenocarcinomas.
Discussion
We studied the effect of fast and reliable point mutation analysis for the detection of malignancy using fine needle aspiration biopsy specimens of pancreatic lesions. Our results show that the specificity and sensitivity of K-ras point mutation analysis of ultrasound guided pancreatic fine needle biopsy specimens are as good as those of standard microscopic cytology. K-ras point mutations occur in up to 90% of pancreatic adenocarcinomas. 9 In this study all carcinomas diagnosed on cytology also had a point mutation.
Samples In these cases we could not confirm the presence of a point mutation using specific nucleotide incorporation analysis. This may be because only one nucleotide is present in the specific reaction. In the screening reaction three different nucleotides are available, enabling the polymerase to elongate the chain following mutation. The extra nucleotides potentiate the search for mutations. Thus, the reaction may be more sensitive to very small amounts of mutated alleles if a mixture containing all three possible mutant nucleotides is used. Magnetic microspheres can also be used as a solid phase, increasing the sensitivity of the assay.' 12 The methods used in this study are relatively easy to use and maintain, and can be modified and adapted to non-radioactive detection systems. The protocols can be standardised and the procedure is almost identical for any known point mutation, facilitating the analysis of multiple point mutations in a single minisequencing series.
In conclusion, PCR based analysis of ultrasound guided fine needle biopsy material is a promising method for enhancing diagnostic accuracy in central cytopathology laboratories. The basic principles of diagnostic cytology, however, must also be taken into account.
